Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

For cervical cancer patients in Saskatchewan, the new Interstitial High-Dose-Rate (HDR) Gynecological Brachytherapy program ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher ...

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

He revealed, “The aim of radiation therapy is to deliver a precise measured dose of radiation to a defined tumour volume with ...

Papua New Guinea has taken a significant step forward in cancer care with the reintroduction of brachytherapy at Angau Memorial Hospital, bolstering its radiation medicine services. This milestone ...

Brigette Douglass, initially mistaking her vision loss for a migraine, learned she had uveal melanoma, a rare and fast-spreading form of eye cancer. Douglass received an innovative plaque ...

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II drugs for Uterine Cancer have a 30% phase transition success rate ...

Regrettably, over the past year or two, we have faced challenges in obtaining tumor tissue samples post-radiotherapy for endometrial cancer due to various reasons. Specifically, the survival status of ...

Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...